Skip to main content

Table 2 Prediction of 5-HT1B, 5-HT1D, and 5-HT1F receptor occupancy levels in the PNS and CNS. The trigeminal ganglion (TG) represents the PNS region, while whole brain (WB) represents the CNS region. Predictions are based on unbound maximal target site concentrations after therapeutic doses of eletriptan and sumatriptan in humans

From: Regional distribution of unbound eletriptan and sumatriptan in the CNS and PNS in rats: implications for a potential central action

Parameter

Unit

Site

Eletriptan

Sumatriptan

PO 40 mg

PO 50 mg

PO 100 mg

Kd,5−HT1B [51]

nM

NA

3.14

11.07

Kd,5−HT1D [51]

nM

NA

0.92

6.58

Ki,5−HT1F [51]

nM

NA

10.23

13.18

fu, plasma [50]

  

0.13

0.66

Ctot, max [35, 36]

nM or (ng/mL)

Plasma

246 (94.0)

102 (30.1)

180 (53.2)

Cu, max

nM or (ng/mL)

Plasma

32.2 (12.3)

67.3 (19.9)

119 (35.1)

Cu, max, ROI

nM

TG

16.6

62.1

109.8

Cu, max, ROI

nM

WB

1.86

3.00

5.31

RO5−HT1B

%

TG

84

85

90

RO5−HT1B

%

WB

37

21

32

RO5−HT1D

%

TG

95

90

94

RO5−HT1D

%

WB

67

31

45

RO5−HT1F

%

TG

62

82

89

RO5−HT1F

%

WB

15

19

29

  1. PO peroral, TG trigeminal ganglion, WB whole brain, RO receptor occupancy. The Cu,max,ROI has been calculated according to Eq. 17. The RO has been calculated according to Eq. 16. NA not applicable